Mandarin Oriental International Ltd
F:1C4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mandarin Oriental International Ltd
F:1C4
|
HK |
|
Sequana Medical NV
F:2SE
|
BE |
|
L
|
Lepermislibre SA
PAR:ALLPL
|
FR |
|
M
|
Medifast Inc
XBER:MDF
|
US |
|
Sugal and Damani Share Brokers Ltd
BSE:511654
|
IN |
|
O
|
Otto Energy Ltd
SWB:O1E
|
AU |
|
L
|
Lee & Man Paper Manufacturing Ltd
F:LMP
|
HK |
|
Australian Oil Company Ltd
ASX:AOK
|
AU |
|
F
|
First Industrial Realty Trust Inc
BMV:FR
|
US |
|
Bob's Discount Furniture, Inc
NYSE:BOBS
|
US |
|
C
|
Corcept Therapeutics Inc
XBER:HTD
|
US |
|
C
|
Canadian Tire Corporation Ltd
SWB:YAAA
|
CA |
|
ITEX Corp
OTC:ITEX
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is 1C4's stock price target?
Not Available
1C4 doesn't have any price targets made by Wall Street professionals.
What is Mandarin Oriental International Ltd's Revenue forecast?
Projected CAGR
-7%
For the last 13 years the
compound annual growth rate for
Mandarin Oriental International Ltd's revenue is
-1%.
The projected
CAGR
for the next 1 year is
-7%.
What is Mandarin Oriental International Ltd's Operating Income forecast?
Projected CAGR
-76%
For the last 13 years the
compound annual growth rate for
Mandarin Oriental International Ltd's operating income is
0%.
The projected
CAGR
for the next 1 year is
-76%.